BARRETT'S ESOPHAGUS: Reducing the Risk of Progression to Adenocarcinoma
- 1 December 1999
- journal article
- review article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 28 (4) , 917-945
- https://doi.org/10.1016/s0889-8553(05)70098-4
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Diagnostic value of p53 immunohistochemistry in Barrett's esophagus: An endoscopic studyPathology, 1998
- Rising incidence rate of esophageal adenocarcinoma and use of pharmaceutical agents that relax the lower esophageal sphincter (United States)Cancer Causes & Control, 1994
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53Published by Elsevier ,1992
- Adenocarcinomas arising in tongues or short segments of Barrett's esophagusDigestive Diseases and Sciences, 1992
- The p53 tumour suppressor geneNature, 1991
- The consumption of tobacco, alcohol and the risk of adenocarcinoma in Barrett's oesophagusInternational Journal of Cancer, 1990
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Barrett's EsophagusNew England Journal of Medicine, 1986
- Regression of Columnar Esophageal (Barrett's) Epithelium after Anti-Reflux SurgeryNew England Journal of Medicine, 1980